Hienrich Edi 4

4 · HERBALIFE NUTRITION LTD. · Filed Dec 7, 2020

Form 4

Period: 2020-12-03

SVP/Managing Director EMEA

Transactions

Tax Payment
Common Stock
2020-12-03$49.72/sh−10,872$540,556→ 37,657 total
Exercise/Conversion
Common Stock
2020-12-03$31.25/sh+26,872$839,884→ 64,529 total
Exercise/Conversion
Stock Appreciation Rights
2020-12-03−15,000→ 0 total
Exercise: $23.90From: 2018-05-07Exp: 2025-05-07→ Common Stock (15,000 underlying)
Tax Payment
Common Stock
2020-12-03$49.72/sh−21,584$1,073,156→ 42,945 total
Exercise/Conversion
Common Stock
2020-12-03$23.90/sh+15,000$358,500→ 48,529 total
Sale
Common Stock
2020-12-04$49.88/sh−6,241$311,301→ 36,704 total
Sale
Common Stock
2020-12-07$49.88/sh−9,416$469,629→ 27,288 total
Exercise/Conversion
Stock Appreciation Rights
2020-12-03−26,872→ 0 total
Exercise: $31.25From: 2019-05-09Exp: 2026-05-09→ Common Stock (26,872 underlying)

Holdings

Footnotes (5)

[F1]This transaction was executed in multiple trades at prices ranging from $49.87 to $49.88. The price reported reflects the weighted average sale price of $49.8756. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
[F2]Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as part of an award covering 12,500 shares at an exercise price of $47.80 per share.
[F3]The SARs were granted on May 7, 2015. 20% vested on May 7, 2016, 20% vested on May 7, 2017 and the remaining 60% vested on May 7, 2018.
[F4]Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as part of an award covering 16,795 shares at an exercise price of $62.51 per share.
[F5]The SARs were granted on May 9, 2016. 20% vested on May 9, 2017, 20% vested on May 9, 2018 and the remaining 60% vested on May 9, 2019.

Documents

1 file